Chronic obstructive pulmonary disease (COPD) affects one-tenth of the world's population
and has been identified as a major global unmet health need by the World Health …

Early stage COPD carries a significant healthcare burden that is currently underrecognised,
underdiagnosed and undertreated. Furthermore, patients at this stage can rapidly decline to …

Chronic obstructive pulmonary disease (COPD) is the third leading cause of death
worldwide. COPD, however, is a heterogeneous collection of diseases with differing causes …

Background: Chronic obstructive pulmonary disease (COPD) is a common multi‐component
disease that imposes an enormous burden on the patient, the healthcare professional and …

Chronic obstructive pulmonary disease (COPD) is a prevalent, heterogeneous disorder with
varying presentation and progression but with a limited number of disease-modifying …

Chronic obstructive pulmonary disease (COPD) is the most common chronic lung disease in
the world, and its associated health burdens and costs are mounting. Until recently, it was …

The early stages of COPD have recently become a hot topic as many new risk factors have
been proposed, but substantial knowledge gaps remain in explaining the natural history of …

Aims Chronic obstructive pulmonary disease (COPD) is usually a progressive condition.
Undiagnosed early‐stage disease, particularly in symptomatic patients, is likely to become …

Chronic obstructive pulmonary disease (COPD) is a chronic disorder with substantial
comorbidity and major effects attributable to the high morbidity and mortality rates. Despite …

Chronic obstructive pulmonary disease (COPD) is currently a leading cause of death
worldwide, and its burden is expected to rise in the coming years. Common COPD …